StockData
Alamar Biosciences, Inc. logo

Alamar Biosciences, Inc. (ALMR) stock

ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)

Close on Nov 17, 2026Market cap $2.13BP/E –Yield –

Alamar Biosciences cash

Cash and short-term investments held at the end of each period.

Alamar Biosciences's cash was $226.59M at Sep 30, 2026. For fiscal 2025 it was $30.00M.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.00M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$226.59M+375.6%
Q2 FY2026Jun 30, 2026$250.05M–
Q1 FY2026Mar 31, 2026$64.59M–
Q4 FY2025Dec 31, 2025$30.00M–
Q3 FY2025Sep 30, 2025$47.64M–

More Alamar Biosciences figures

See a number that looks wrong?